Alan W. Dunton

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
10 years
Director since
2023

10 years of board service in total across 3 boards, counting each seat separately. Longest: CorMedix Inc., 3 years.

CorMedix Inc. Director
3 years ยท Since 2023
3 years ยท Since 2023
Oragenics Inc. Director
3 years ยท Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jan 26, 2026 CorMedix Inc. Grant or award +30,453 โ€” โ€”
Dec 30, 2025 CorMedix Inc. Option exercise +20,000 $4.03 $80,600
Dec 30, 2025 CorMedix Inc. Open-market sale โˆ’20,000 $13.00 $260,000
Dec 9, 2025 Palatin Technologies Inc. Grant or award +1,000 โ€” โ€”
Dec 9, 2025 Palatin Technologies Inc. Grant or award +1,000 โ€” โ€”
Sep 12, 2025 CorMedix Inc. Option exercise +10,000 $3.55 $35,500
Sep 12, 2025 CorMedix Inc. Open-market sale โˆ’10,000 $13.13 $131,300
Jun 13, 2025 Palatin Technologies Inc. Open-market purchase +200 $20,000.00 $4,000,000
Jan 17, 2025 CorMedix Inc. Grant or award +25,000 โ€” โ€”
Dec 6, 2024 Oragenics Inc. Open-market sale โˆ’66 $0.36 $24
Jul 15, 2024 Palatin Technologies Inc. Grant or award +12,000 โ€” โ€”
Dec 15, 2023 CorMedix Inc. Open-market purchase +3,000 $3.30 $9,900
Dec 14, 2023 CorMedix Inc. Open-market purchase +3,000 $3.45 $10,350
Dec 4, 2023 Palatin Technologies Inc. Open-market sale โˆ’199 $2.48 $494
Dec 4, 2023 Palatin Technologies Inc. Open-market sale โˆ’1 $2.46 $2

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.